# AustarPharma, LLC – FDA Inspection, Dec 4, 2024

Source: https://www.keypedia.com/records/fda_inspections/austarpharma-llc/10e2a2db-5b56-49da-a13d-88339fba8141
Source feed: FDA_Inspections

> FDA inspection 1236866 of AustarPharma, LLC, December 04, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 314. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1236866
- Company Name: AustarPharma, LLC
- Inspection Date: 2024-12-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1201798 - 2023-04-05](https://www.keypedia.com/records/fda_inspections/austarpharma-llc/6635b5b3-6703-455e-b2f0-5a25ec8bc2b8)
- FDA Inspection 1080178 - 2019-02-11
- [FDA Inspection 1052925 - 2018-05-23](https://www.keypedia.com/records/fda_inspections/austarpharma-llc/4648d24c-7e56-4666-af77-cc2fc35305a9)
- [FDA Inspection 1037881 - 2018-01-05](https://www.keypedia.com/records/fda_inspections/austarpharma-llc/f067f0ec-7152-46ca-bde6-1691f99a71ce)
- [FDA Inspection 1015357 - 2017-06-22](https://www.keypedia.com/records/fda_inspections/austarpharma-llc/ff5437cf-d90b-484a-b3f3-d1c17a53201a)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)

Company: https://www.keypedia.com/companies/austarpharma-llc/05a402ea-dcb1-4900-9553-0a3a1b908183

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
